The FDA has paused a study of Amgen’s early-stage candidate AMG 513. Elsewhere, Valneva got another approval and a radiopharma developer raised $112 million.
The most talked about and market moving research calls around Wall Street are now in one place. Here are today’s research calls that investors ...
Hello, and welcome, everyone, to the Cencora Q1 fiscal year 2025 earnings call. My name is Becky, and I'll be your operator today. (Operator Instructions) I will now hand over to your host, Head of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback